outcomes in patients with ms who receive immune checkpoint inhibitors as cancer treatment
Published 4 months ago • 77 plays • Length 7:46Download video MP4
Download video MP3
Similar videos
-
5:33
cancer immune checkpoint inhibitors
-
2:48
impact of prior antibiotic exposure on the outcomes of immune checkpoint inhibitor immunotherapy
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
58:49
curing metastatic solid tumours with immune checkpoint inhibitors by professor james larkin
-
2:45
correlation between cutaneous immune-related adverse events and os with immune checkpoint inhibitors
-
1:33
checkpoint inhibitors: correlation between side effects and patient outcomes
-
27:43
targeting the immune system with checkpoint inhibitors
-
14:42
managing toxicities associated with immune-checkpoint inhibitors
-
45:59
immune checkpoint inhibitors in solid tumours
-
3:48
overcoming resistance to immune checkpoint inhibitors in nsclc
-
29:57
immune checkpoint inhibitors with dr. kerry reynolds
-
1:44
immune checkpoint inhibitors in mcrpc
-
4:05
neuroimmunological adverse events associated with immune checkpoint inhibitors
-
23:20
new checkpoint inhibitors & immunotherapy in metastatic melanoma - michael postow md
-
2:22
movement disorders in oncology: immune checkpoint inhibitors
-
12:48
impact of immune checkpoint inhibitors
-
56:25
dissecting toxicities of immune checkpoint inhibitors with dr. douglas johnson, m.d., msci
-
1:02:47
“rheumatologic consequences of immune checkpoint inhibitors”, annual kessler lecture, dr. ami shah
-
3:30
side effects of immune checkpoint inhibitors